Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis.
Saved in:
| Title: | Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis. |
|---|---|
| Authors: | Hu, Zixin1,2 (AUTHOR), Zheng, Yumin2,3 (AUTHOR), Zheng, Jiabin2 (AUTHOR), Wang, Yan4 (AUTHOR), Liao, Jiangquan4 (AUTHOR), Liu, Zhening2,3 (AUTHOR), Li, Jia2,3 (AUTHOR), Cui, Huijuan2 (AUTHOR) cuihj1963@sina.com |
| Source: | Cancer Medicine. Jun2024, Vol. 13 Issue 11, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
